K. Hsu

发表

Expression and HLA Binding Polymorphisms Disrupt KIR3DL1 Surface KIR3DS1-Specific D0 Domain

Y. Goldgur, J. Boudreau, K. Hsu, 2015 .

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

I. Ostrovnaya, K. Hsu, D. Goldman, 2018, Oncoimmunology.

CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

M. Czuczman, B. Cheson, Sin-Ho Jung, 2014, Cancer Immunology Research.

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function following T-cell depleted allogeneic

K. Hsu, J. Venstrom, Junli Yu, 2016 .

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.

K. Hsu, R. O'reilly, J. Venstrom, 2009, Blood.

Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.

K. Hsu, B. Dupont, B. DuPont, 2005, Seminars in hematology.

Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity.

K. Hsu, B. Shaffer, 2020, Seminars in hematology.

Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection

K. Hsu, B. Shaw, K. Fleischhauer, 2018, Bone Marrow Transplantation.

How important is NK alloreactivity and KIR in allogeneic transplantation?

K. Hsu, B. Shaffer, 2016, Best practice & research. Clinical haematology.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.

N. Kröger, P. Hari, M. Bishop, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

J. Chewning, K. Hsu, B. Dupont, 2012, The New England journal of medicine.

Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.

M. Altfeld, K. Hsu, W. Yokoyama, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural killer cells: alloreactive effects in hematopoietic stem cell transplantation

K. Hsu, 2010 .

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

Imaging , Diagnosis , Prognosis KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

K. Hsu, B. Dupont, Junting Zheng, 2009 .

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

K. Hsu, B. Dupont, Junting Zheng, 2009, Clinical Cancer Research.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

F. Christiansen, A. Gratwohl, K. Hsu, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.

K. Hsu, B. Dupont, M. Malkki, 2007, Tissue antigens.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands

J. Chewning, K. Hsu, G. Heller, 2007, The Journal of Immunology.

Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1

J. Chewning, K. Hsu, G. Heller, 2007, The Journal of Immunology.

Self-HLA-B and HLA-C Ligands Quantity of Inhibitory Receptors for Response Is Determined by Class and Hierarchy of the Human Natural Killer Cell

J. Chewning, K. Hsu, G. Heller, 2007 .

Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for SelfHLA SelfHLA SelfHLA-B and HLAC HLAC HLAC Ligands 1

J. Chewning, K. Hsu, G. Heller, 2007 .

TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

J. Satagopan, G. Papanicolaou, P. Peterlongo, 2005, Annals of the New York Academy of Sciences.

Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2017, The New England journal of medicine.

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant

K. Hsu, Stephanie J. Lee, S. Spellman, 2020, Leukemia & lymphoma.

Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

J. Boudreau, K. Hsu, 2018, Trends in immunology.

Genotyping Natural Killer Immune Checkpoints to Discover Biomarkers of Response

N. Cheung, K. Hsu, 2017, Clinical Cancer Research.

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

K. Hsu, G. Heller, Junting Zheng, 2012, The Journal of clinical investigation.

KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.

J. Boudreau, K. Hsu, G. Heller, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor.

N. Cheung, K. Hsu, I. Cheung, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro1

J. Chewning, K. Hsu, A. Selvakumar, 2007, The Journal of Immunology.

HLA alleles determine differences in human natural killer cell responsiveness and potency

J. Piccirillo, M. Colonna, M. Cella, 2008, Proceedings of the National Academy of Sciences.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

D. Porter, M. Horowitz, K. Hsu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Chemotherapy-only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of Myeloid Malignancies

M. Perales, K. Hsu, James W. Young, 2018 .

A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.

M. Perales, M. V. D. van den Brink, K. Hsu, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Human Tumor Necrosis Factor (TNF) c~ Mutant That Binds Exclusively to the p55 TNF Receptor Produces Toxicity in the Baboon By Kimberly

S. Calvano, L. Moldawer, S. Lowry, 2003 .

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Immunogenetics.

Role of HLA-B Exon 1 in Graft-versus-Host Disease After Unrelated Donor Transplantation: A Retrospective Cohort Study

K. Hsu, M. Maiers, M. Malkki, 2020 .

HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation.

M. Carrington, M. Horowitz, K. Hsu, 2020, Blood.

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

B. Barlogie, G. Tricot, K. Hsu, 2008, British journal of haematology.

HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.

K. Hsu, E. Petersdorf, T. Gooley, 2020, Blood advances.

HLA-A alleles in ﬂ uencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation

K. Hsu, E. Petersdorf, T. Gooley, 2020 .

KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding

Y. Goldgur, J. Boudreau, K. Hsu, 2015, The Journal of Immunology.

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.

J. Boudreau, K. Hsu, Aaron C. Zhang, 2016, Immunity.

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes.

V. Brown, K. Hsu, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response by Activating Unlicensed NK Cells CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma

M. Czuczman, B. Cheson, B. Pitcher, 2014 .

Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance

J. Boudreau, K. Hsu, J. Le Luduec, 2019, Front. Immunol..

Receptor KIR2DS1 in Individuals with NK Cell Tolerance of Self-Specific Activating

Ernesto Merino, M. Huse, K. Hsu, 2017 .

NK Cell Tolerance of Self-Specific Activating Receptor KIR2DS1 in Individuals with Cognate HLA-C2 Ligand

J. Chewning, Ernesto Merino, M. Huse, 2013, The Journal of Immunology.

Cognate HLA-C 2 Ligand Receptor KIR 2 DS 1 in Individuals with NK Cell Tolerance of Self-Specific Activating Chewning

J. Chewning, Ernesto Merino, M. Huse, 2013 .

Natural killer cell education in human health and disease.

J. Boudreau, K. Hsu, 2018, Current opinion in immunology.

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.

M. Perales, S. Devlin, K. Hsu, 2020, Blood advances.

Novel multiplex PCR-SSP method for centromeric KIR allele discrimination

J. Boudreau, K. Hsu, J. Le Luduec, 2018, Scientific Reports.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

E. Reed, J. Boudreau, K. Hsu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV

J. Boudreau, K. Hsu, E. Barker, 2016, The Journal of Immunology.

This information is current as HIV Calibrate NK Education and Response to KIR 3 DL 1 and HLA-B Density and Binding Luduec

J. Boudreau, K. Hsu, E. Barker, 2016 .

Development of a Novel Multiplex PCR Assay to Detect Functional Subtypes of KIR3DL1 Alleles

J. Boudreau, K. Hsu, J. Le Luduec, 2014, PloS one.

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.

M. Perales, K. Hsu, James W. Young, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.

K. Hsu, B. DuPont, 2004, Current opinion in immunology.

Phenotypic and Functional Activation of Hyporesponsive KIRnegNKG2Aneg Human NK-Cell Precursors Requires IL12p70 Provided by Poly(I:C)-Matured Monocyte-Derived Dendritic Cells

K. Hsu, James W. Young, E. Romano, 2014, Cancer Immunology Research.

No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

S. Savage, K. Hsu, Stephanie J. Lee, 2017, Bone Marrow Transplantation.

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

K. Hsu, Jeffrey S. Miller, J. Fischer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade

K. Hsu, G. Heller, James W. Young, 2016, Cancer Immunology Research.

Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK 1 / 2 Blockade Running Title : DCs mitigate NK dysfunction from JAK 1 / 2 inhibition

K. Hsu, J. Chung, G. Heller, 2016 .

Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature

Joseph C. Sun, K. Hsu, T. Mertens, 2021, The Journal of Immunology.

Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.

M. Perales, M. V. D. van den Brink, J. Chewning, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.

J. Goldberg, M. Perales, R. Jenq, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.

J. Massagué, U. Bhanot, M. Huse, 2021, Immunity.

Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells.

Joseph C. Sun, M. Huse, K. Hsu, 2019, Immunity.

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

M. Horowitz, K. Hsu, G. Heller, 2005, Blood.

Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.

S. Jhanwar, M. Perales, M. V. D. van den Brink, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation.

J. Teruya-Feldstein, D. Hyman, K. Hsu, 2014, Clinical lymphoma, myeloma & leukemia.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A CIBMTR Study

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019 .

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

M. Carrington, C. Witt, R. Apps, 2014, Blood.

Cytotoxic lymphocytes use mechanosurveillance to target biophysical vulnerabilities in cancer

J. Massagué, M. Huse, K. Hsu, 2020, bioRxiv.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

S G E Marsh, D E Geraghty, P Parham, 2003, Immunogenetics.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Tissue antigens.

The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR

A. Nagler, M. Mohty, K. Hsu, 2018, Bone Marrow Transplantation.

The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism

K. Hsu, D. Geraghty, Bo Dupont, 2002, Immunological reviews.

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.

J. Teruya-Feldstein, M. Arcila, M. Perales, 2020, The Journal of clinical investigation.

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

M. Perales, R. Jenq, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

M. Carrington, E. Tholouli, C. Crawley, 2019, The Lancet. Haematology.

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

J. Goldberg, M. Perales, R. Jenq, 2015, Blood.

Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1

Eric Mickelson, Katharine C. Hsu, K. Hsu, 2002, The Journal of Immunology.

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.

G. Papanicolaou, M. Perales, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

K. Hsu, J. Pidala, Stephanie J. Lee, 2018, Blood advances.

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Bone Marrow Transplantation.

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML.

S. Devlin, K. Hsu, S. Giralt, 2021, Blood advances.

KIR3DL1 and HLA-Bw4 Allotypes Predict The Extent Of NK Cell Licensing

K. Hsu, Jean-Benoît Le Luduec, 2013 .

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

Bo Dupont, Derek Middleton, John Trowsdale, 2003, Immunogenetics.

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

K. Hsu, Stephanie J. Lee, O. Ringdén, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis

J. Lünemann, I. Jelcic, Roland Martin, 2012, Multiple sclerosis.

MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Mar

K. Hsu, Stephanie J. Lee, A. Madbouly, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation

Sherri Rose, S. Haneuse, K. Hsu, 2018, PloS one.

Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy

K. Hsu, G. Heller, R. O'reilly, 2022, Blood Advances.

Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia

K. Hsu, Stephanie J. Lee, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity

Joseph C. Sun, K. Hsu, R. Brentjens, 2021, Science Immunology.

Deconvoluting global cytokine signaling networks in natural killer cells

Joseph C. Sun, K. Hsu, Celeste Dang, 2021, Nature Immunology.

Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.

V. Paunic, K. Hsu, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

B. Barlogie, J. Shaughnessy, G. Tricot, 2005 .

Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness

G. Altan-Bonnet, Joseph C. Sun, K. Hsu, 2021, Science Signaling.

KIR and HLA genotypes have no identifiable role in single unit dominance following double unit umbilical cord blood transplantation

K. Hsu, G. Heller, J. Chou, 2014, Bone Marrow Transplantation.

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2016 .

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation

R. Strong, K. Hsu, M. Malkki, 2023, Blood advances.

Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies.

M. Perales, R. Jenq, K. Hsu, 2009 .

Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML

K. Hsu, M. Malkki, E. Petersdorf, 2005 .

13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel.

M. Carrington, F. Christiansen, C. Witt, 2006 .

Differential expression and ligand binding properties of tumor necrosis factor receptor chimeric mutants.

K. Hsu, M. Chao, M. Chao, 1993, The Journal of biological chemistry.

Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia

A. McPherson, O. Abdel-Wahab, B. Greenbaum, 2023, Blood advances.

SubsetsFramework Haplotypes, Each with Multiple Diversity with a Minimum of Six Basic by Gene Content: Evidence for Genomic Killer Ig-Like Receptor Haplotype Analysis

K. Hsu, R. O'reilly, A. Selvakumar, 2002 .

How important is NK alloreactivity and KIR in allogeneic transplantation?

K. Hsu, B. Shaffer, 2016, Best practice & research. Clinical haematology.

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT

J. Goldberg, M. Perales, R. Jenq, 2010, Bone Marrow Transplantation.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

R. Apps, A. Velardi, K. Hsu, 2014, Blood.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Tissue Antigens.